MacMODR's profile picture. McMaster's Centre for Metabolism, Obesity & Diabetes Research translates world leading basic science into clinical practice to improve metabolic disease.

@MacMODR

@MacMODR

McMaster's Centre for Metabolism, Obesity & Diabetes Research translates world leading basic science into clinical practice to improve metabolic disease.

New research in @CommsMedicine from @machealthsci & @PHRIresearch investigators shows that hidden abdominal & liver fat may silently harm arteries even in those who look healthy. healthsci.mcmaster.ca/skinny-fat-lin…

MacMODR's tweet image. New research in @CommsMedicine from @machealthsci & @PHRIresearch investigators shows that hidden abdominal & liver fat may silently harm arteries even in those who look healthy.
healthsci.mcmaster.ca/skinny-fat-lin…

@MacMODR reposted

MASH: the nexus of metabolism, inflammation and fibrosis This review by Gregory R. Steinberg @DrGregSteinberg & colleagues @McMasterU is part of JCI’s ongoing series, Evolving Insights into #MASLD and MASH Pathogenesis and Treatment with series editor Scott Friedman:…

jclinicalinvest's tweet image. MASH: the nexus of metabolism, inflammation and fibrosis

This review by Gregory R. Steinberg @DrGregSteinberg  & colleagues @McMasterU is part of JCI’s ongoing series, Evolving Insights into #MASLD and MASH Pathogenesis and Treatment with series editor Scott Friedman:…

@MacMODR reposted

Targeting hepatocyte and tumour lipid metabolism through ACLY inhibition promotes B-cell infiltration/aggregation via CXCL13, resulting in reduced tumour burden in MASH-HCC mouse models nature.com/articles/s4158…


“This is one of the first studies to show that targeting metabolism in tumours can enable the immune system to kill liver cancer cells, and opens the door to more effective prevention and treatment strategies for this deadly disease,” @DrGregSteinberg healthsci.mcmaster.ca/mcmaster-resea…

healthsci.mcmaster.ca

Promising new treatment for liver cancer

Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease. But researchers at McMaster University in collaboration with...


@MacMODR reposted

New! Online now: Gut substrate trap of D-lactate from microbiota improves blood glucose and fatty liver disease in obese mice dlvr.it/TMB0yf

Cell_Metabolism's tweet image. New!  Online now: Gut substrate trap of D-lactate from microbiota improves blood glucose and fatty liver disease in obese mice dlvr.it/TMB0yf

@MacMODR reposted

Researchers from across @McMasterU’s Faculty of Health Sciences have secured nearly $19M from @CIHR_IRSC’s Spring 2025 Project Grant Competition. Explore the full list of newly funded research teams and topics 👇 ow.ly/V8ab50WwI1S


Published in @Nature, the findings offer a promising path to better prevention & treatment strategies. nature.com/articles/s4158…

Liver cancer rates are📈in Canada, driven by #fattyliverdisease 🔗to #obesity & #diabetes. Current treatments are limited. Researchers @MacMODR & #EspervitaTherapeutics developed a drug that blocks fat production in tumors, helping #Bcells attack cancer.

MacMODR's tweet image. Liver cancer rates are📈in Canada, driven by #fattyliverdisease 🔗to #obesity & #diabetes. Current treatments are limited. Researchers @MacMODR & #EspervitaTherapeutics developed a drug that blocks fat production in tumors, helping #Bcells attack cancer.


Liver cancer rates are📈in Canada, driven by #fattyliverdisease 🔗to #obesity & #diabetes. Current treatments are limited. Researchers @MacMODR & #EspervitaTherapeutics developed a drug that blocks fat production in tumors, helping #Bcells attack cancer.

MacMODR's tweet image. Liver cancer rates are📈in Canada, driven by #fattyliverdisease 🔗to #obesity & #diabetes. Current treatments are limited. Researchers @MacMODR & #EspervitaTherapeutics developed a drug that blocks fat production in tumors, helping #Bcells attack cancer.

@MacMODR reposted

Here Professor Schertzer and colleagues identify that microbial-derived D-lactate contributes to host glucose and lipid metabolism and can be trapped therapeutically to improve metabolic disease during #obesity cell.com/cell-metabolis…


@MacMODR reposted

Researchers from @McMasterU @universitelaval @uOttawa have made a discovery that could open the door to new therapies to treat metabolic diseases like type 2 diabetes and fatty liver disease. Learn more: healthsci.mcmaster.ca/trapping-gut-b… @CIHR_IRSC @Farncombe_GI @MacMODR


New findings from @Schertzerlab out in @cellmetabolism show that trapping microbial D-lactate in the gut ⬇️#bloodglucose, #liverinflammation & #fibrosis in #obese mice. D-lactate⬆️#bloodglucose through a shunt in the #Coricycle, adding to a 100-year-old discovery.

MacMODR's tweet image. New findings from @Schertzerlab out in @cellmetabolism show that trapping microbial D-lactate in the gut ⬇️#bloodglucose, #liverinflammation & #fibrosis in #obese mice. D-lactate⬆️#bloodglucose through a shunt in the #Coricycle, adding to a 100-year-old discovery.


New findings from @Schertzerlab out in @cellmetabolism show that trapping microbial D-lactate in the gut ⬇️#bloodglucose, #liverinflammation & #fibrosis in #obese mice. D-lactate⬆️#bloodglucose through a shunt in the #Coricycle, adding to a 100-year-old discovery.

MacMODR's tweet image. New findings from @Schertzerlab out in @cellmetabolism show that trapping microbial D-lactate in the gut ⬇️#bloodglucose, #liverinflammation & #fibrosis in #obese mice. D-lactate⬆️#bloodglucose through a shunt in the #Coricycle, adding to a 100-year-old discovery.

Another great addition to our March 6 seminar is Maya Bozzo-Rey – MSc (c) in @SergiClotet lab. Her presentation will explore kidney metabolism, epigenetics & sex differences in DKD, with a focus on metabolic responses to high glucose & epigenetic modifications.

MacMODR's tweet image. Another great addition to our March 6 seminar is Maya Bozzo-Rey – MSc (c) in @SergiClotet lab. Her presentation will explore kidney metabolism, epigenetics & sex differences in DKD, with a focus on metabolic responses to high glucose & epigenetic modifications.

Also presenting on March 6 is Meghan Conn – 2nd year MSc (c) in the @SchertzerLab. @MeghanConn01's presentation will describe the metabolic changes that occur during repeated intermittent fasting(IF) & how features of obesity & early T2D affect the metabolic response to IF

MacMODR's tweet image. Also presenting on March 6 is Meghan Conn – 2nd year MSc (c) in the @SchertzerLab. @MeghanConn01's presentation will describe the metabolic changes that occur during repeated intermittent fasting(IF) & how features of obesity & early T2D affect the metabolic response to IF

Join us on March 6 for the next MODR Seminar, featuring #MODRtrainee Ann Kuganathan - 4th-year PhD(c) in the Krepninsky lab. @annswathyk will share her research on how follistatin improves vascular health & PVAT function in hypertension. 🔗…bolism-research.healthsci.mcmaster.ca/events/modr-se…

MacMODR's tweet image. Join us on March 6 for the next MODR Seminar, featuring #MODRtrainee Ann Kuganathan - 4th-year PhD(c) in the Krepninsky lab.  @annswathyk will share her research on how follistatin improves vascular health & PVAT function in hypertension.

🔗…bolism-research.healthsci.mcmaster.ca/events/modr-se…

@MacMODR reposted

Good luck to all the learners, research staff, as well as family partners and new investigators putting the finishing touches on their #MCHRD2025 abstracts! Remember to submit your abstracts by this Wed. Feb. 26 at 11:59 PM EST via the MCHRD website ⬇️ pediatrics.healthsci.mcmaster.ca/research/mcmas…

McMasterCHR's tweet image. Good luck to all the learners, research staff, as well as family partners and new investigators putting the finishing touches on their #MCHRD2025 abstracts!

Remember to submit your abstracts by this Wed. Feb. 26 at 11:59 PM EST via the MCHRD website ⬇️
pediatrics.healthsci.mcmaster.ca/research/mcmas…

Loading...

Something went wrong.


Something went wrong.